311 – 320 of 333
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Prostate cancer - Prevalence-based healthcare costs
(
- Contribution to journal › Article
-
Mark
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
(
- Contribution to journal › Article
- 2002
-
Mark
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
(
- Contribution to journal › Article
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
(
- Contribution to journal › Article
-
Mark
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing
(
- Contribution to journal › Article
- 2000
-
Mark
Experiences of micturition problems, indwelling catheter treatment and sexual life consequences in men with prostate cancer
(
- Contribution to journal › Article
-
Mark
Everyday problems in men with prostate cancer. Aspects of micturition, indwelling urinary catheter treathment and sexual life
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human glandular kallikrein 2 (hK2) in prostate cancer: Clinical and Methodological studies
2000)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article